FlaggedRx← Medication recall checkHome
Class III · Lower riskRecall completed

Lisinopril

Unlikely to cause harm — often a labeling or packaging issue.

Does this affect you?
Check your lot numberLot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13
Where it was soldNationwide
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byAurobindo Pharma Limited Hyderabad- 500 072 India foreign manufacturer
Brand nameLISINOPRIL
Generic nameLISINOPRIL
Active ingredient(s)LISINOPRIL
Distributed by / forAurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810
NDC65862-041-01
Show the full FDA record
Full product labelLisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India
Recalling firmAurobindo Pharma USA Inc
DistributionNationwide
Quantity1776 bottles
Recall initiated2013-04-09
Report date2013-06-05
Recall completed2014-01-23
Recall numberD-498-2013
ClassificationClass III
FDA statusTerminated
Origin on filePlainsboro NJ United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.